Friday, June 01, 2007

Even China will Admit the Connection....

Beijing- Widespread pollution has caused cancer to become the leading killer
in China, a newspaper reported Monday, citing a government study. A Health
Ministry survey of 30 cities and 78 counties found that rapidly increasing
air and water pollution as well as the use of pesticides and food additives
are the main cause behind the quickly rising cancer rates, the China Daily
reported.

"Many chemical and industrial enterprises are built along rivers so that
they can dump the waste into water easily," Chen Zhizhou, a health expert
with the cancer research institute affiliated with the Chinese Academy of
Medical Sciences, told the newspaper. "Excessive use of fertilizers and
pesticides also pollute underground water. The contaminated water has
directly affected soil, crops and food."

Pollution "is getting worse day by day," he added.

Of the 10 most lethal illnesses recorded last year in China, cancer was
number one, followed by cerebrovascular and heart diseases, the government
survey found.

Major contributors to the cancer rates were found to be air pollution that
causes harmful particles to become lodged in the lungs, formaldehyde and
other compounds used in building renovations and furniture, and additives
used to make livestock grow faster.

More info on Antioxidants and Chemo

There is no evidence that antioxidant supplements interfere with the therapeutic effects of chemotherapy agents, according to a recent systematic review of the use of antioxidants during chemotherapy, available in the May, 2007 issue of the peer-reviewed journal Cancer Treatment Reviews. In fact, they may help increase survival rates, tumor response, and the patient’s ability to tolerate treatment.


This conclusion has important implications for patients whose oncologists discourage the use of antioxidant supplements during treatment. Until now, their concern has been that these supplements may counteract the tumor-shrinking abilities of the chemotherapy.

“This review demonstrates that there is no scientific support for the blanket objection to using antioxidants during chemotherapy. In addition, it also appears that these supplements may help mitigate the side effects of chemotherapy,” said Keith I. Block, MD, lead author of the study and Medical Director of the Block Center for Integrative Cancer Treatment. “This is significant because it increases the likelihood that patients will be able to complete their treatment.”

Co-author Dr. Robert Newman, Professor of Cancer Medicine at M. D. Anderson Cancer Center said, “This study, along with the evolving understanding of antioxidant-chemotherapy interactions, suggests that the previously held beliefs about interference do not pertain to clinical treatment.”

The analysis, titled “Impact of Antioxidant Supplementation on Chemotherapeutic Efficacy: A Systematic Review of the Evidence from Randomized Controlled Trials,” evaluated 845 articles from five scientific databases that examined the effects of taking natural antioxidant supplements concurrent with chemotherapy.

Out of the 845 studies that were analyzed, 19 met all evaluation criteria. These included the use of randomized trials with a control group, and the reporting of treatment response (tumor shrinkage) and survival data. The 1,554 patients represented had a variety of cancer types, and most had advanced or relapsed disease. Some of the antioxidants used in the trials included glutathione, vitamin A, vitamin C, vitamin E, ellagic acid, selenium and beta carotene.

Among the findings:

All of the studies that included survival data showed similar or better survival rates for the antioxidant group than the control group.
None of the trials supported the theory that antioxidant supplements diminish the effectiveness of chemotherapy treatments.
All but one of the studies that reported treatment response showed similar or better response in the antioxidant group than in the control group.
15 of 17 trials that assessed chemotherapy toxicities, including diarrhea, weight loss, nerve damage and low blood counts, concluded that the antioxidant group suffered similar or lower rates of these side effects than the control group.


The authors noted that reducing side effects may help patients avoid having to cut back on their chemotherapy dosing, interrupt scheduled treatments, or abandon treatment altogether. This in turn, is likely to favorably impact treatment outcomes. A recent study of a group of colon cancer patients indicated that those who completed their full prescribed schedules of chemotherapy had survival rates nearly double those of patients who abandoned their chemotherapy treatment prematurely.

This new study encourages further exploration of the potential importance of antioxidant supplements as a means of improving cancer survival.

Note: This story has been adapted from a news release issued by Block Center for Integrative Cancer Treatment.

Breast Cancer and Common Chemicals

The fact that the American Cancer Society and Susan Komen are both recognizing this problems is HUGE!!!!

More than 200 chemicals — many found in urban air and everyday consumer products — cause breast cancer in animal tests, according to a compilation of scientific reports published today.

Writing in a publication of the American Cancer Society, researchers concluded that reducing exposure to the compounds could prevent many women from developing the disease.

The research team from five institutions analyzed a growing body of evidence linking environmental contaminants to breast cancer, the leading killer of U.S. women in their late 30s to early 50s.

Experts say that family history and genes are responsible for a small percentage of breast cancer cases but that environmental or lifestyle factors such as diet are probably involved in the vast majority.

"Overall, exposure to mammary gland carcinogens is widespread," the researchers wrote in a special supplement to the journal Cancer. "These compounds are widely detected in human tissues and in environments, such as homes, where women spend time."

The scientists said data were too incomplete to estimate how many breast cancer cases might be linked to chemical exposures.

But because the disease is so common and the chemicals so widespread, "the public health impacts of reducing exposures would be profound even if the true relative risks are modest," they wrote. "If even a small percentage is due to preventable environmental factors, modifying these factors would spare thousands of women."

The three reports and a commentary were compiled by researchers from the Silent Spring Institute, a women's environmental health organization in Newton, Mass.; Harvard's Medical School and School of Public Health in Boston; the Roswell Park Cancer Institute in Buffalo, N.Y.; and USC's Keck School of Medicine. Silent Spring Institute Executive Director Julia Brody led the team.

In response to the findings, Susan G. Komen for the Cure, a breast cancer prevention group that funded the work, pledged an additional $5 million for developing research tools to root out environmental causes.

Reviewing hundreds of existing studies and databases, the team produced what it called "the most comprehensive compilation to date of chemicals identified as mammary carcinogens." No new chemical testing was conducted for the reports.

The researchers named 216 chemicals that induce breast tumors in animals. Of those, people are highly exposed to 97, including industrial solvents, pesticides, dyes, gasoline and diesel exhaust compounds, cosmetics ingredients, hormones, pharmaceuticals, radiation, and a chemical in chlorinated drinking water.

"Almost all of the chemicals were mutagenic, and most caused tumors in multiple organs and species; these characteristics are generally thought to indicate likely carcinogenicity in humans, even at lower exposure levels," they reported.

For many of the compounds, the federal government has not used animal breast cancer data when conducting human risk assessments, which are the first step toward regulating chemicals or in setting occupational standards to protect workers. Companies are not required to screen women who work with the chemicals for breast cancer.

"Regulators have not paid much attention to potential mammary carcinogens," the researchers wrote.

Toxicologists say that other mammals, such as rats and mice, often develop the same tumors as humans do, and that animal tests are efficient means of testing the effects of chemicals. Environmental regulators, however, often want conclusive human data before taking action.

Animal studies generally use high doses of a substance to simulate a lifetime of exposure, and then the results are extrapolated to the lower levels that people are exposed to.

Ana Soto, a Tufts University professor of cell biology who specializes in cellular origins of cancer and effects of hormone-disrupting contaminants, said there probably was a link between breast cancer and exposures to chemicals in the environment, particularly early in life.

"I cannot say I'm convinced, but what I can say is that it's a very likely, very plausible hypothesis," said Soto, who did not participate in the new research. "More and more, cancer looks like an environmental disease."

Twenty-nine of the chemicals are produced in volumes exceeding 1 million pounds annually in the United States.

Seventy-three are present in consumer products or are food contaminants — 1,4-dioxane in shampoos, for example, or acrylamide in French fries. Thirty-five are common air pollutants, 25 are in workplaces where at least 5,000 women are employed, and 10 are food additives, according to the reports.